O. Rose Broderick reports on the health policies and technologies that govern people with disabilities’ lives. Before coming to STAT, she worked at WNYC’s Radiolab and Scientific American, and her story debunking a bogus theory about transgender kids was nominated for a 2024 GLAAD Media Award. You can reach Rose on Signal at rosebroderick.11.
Three years after researchers first injected deaf children with a treatment designed to give them hearing, an early scientific consensus is emerging: This gene therapy works.
A team of researchers published on Wednesday the most promising results to date: In a clinical trial in China, 90% of participants reported significant improvement in their hearing after receiving an injection. The therapy even improved hearing in a few adults, including a 32-year-old. The results were published in Nature.
“In some patients, the hearing improved so well that they can hear whispers,” said Zheng-Yi Chen, a study author and Mass Eye and Ear otolaryngologist. “To reach a stage where you can hear normal conversation, it’s mind-boggling.”
STAT+ Exclusive Story
Already have an account? Log in
This article is exclusive to STAT+ subscribers
Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.
Already have an account? Log in
Individual plansGroup plans
To read the rest of this story subscribe to STAT+.